The effect of formulation on reduced radioiodide thyroid uptake

Journal of Nuclear Medicine

Volumn 43, Issue 1, 2002, Pages 56-60

  Yu, Ming Der ^a   Huang, Wen Sheng ^a   Cherng, Chiou Chi ^a   Shaw, Stanley M ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

131I; Dissolution test; Radioiodide formulation; Radioiodide thyroid uptake

Indexed keywords

CALCIUM PHOSPHATE DIBASIC; DISODIUM HYDROGEN PHOSPHATE; MAGNESIUM STEARATE; SODIUM IODIDE I 131;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; IODINE 131 UPTAKE TEST; MALE; NODULAR GOITER; PERITONEAL CAVITY; POWDER; PRIORITY JOURNAL; QUALITY CONTROL; SUBACUTE THYROIDITIS; THYROID DISEASE; THYROID GLAND;

ADULT; AGED; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; SODIUM IODIDE; THYROID DISEASES; THYROID GLAND; TIME FACTORS;

EID: 0036157008     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Radioiodine dispensing and usage in a centralized hospital nuclear pharmacy
2. 131I thyroid uptakes: Capsules versus liquid
3. 131I] sodium iodide capsules
4. The effect of additives on the release of drug from hard gelatin capsules
5. In vitro dissolution from several experimental capsule formulations
6. 131I] sodium iodide capsules
7. The effect of formulation on 1-131 dissolution in vitro from sodium iodide capsules
8. The effect of formulation on radioiodide thyroid uptake in the hyperthyroid cat
9. Dissolution test
10. Use of 1-123 for thyroid uptake measurements and depression of 1-131 thyroid uptakes by incomplete dissolution of capsule filler